A randomized controlled trial in Australia suggested that a low dose metoprolol and aspirin for 6 weeks reduces physiological and psychological surrogate measures of cardiovascular risk in early bereavement. After assessment within 2 weeks of bereavement, spouses (n = 73) or parents (n = 12) of deceased (aged 66.1 ± 9.4 years, 55 females) were randomized to 6 weeks of daily metoprolol (25 mg) and aspirin (100 mg) treatment or placebo. Participants of the treatment group had lower levels of home systolic pressure, 24-hour average heart rate, anxiety, platelet response to arachidonic acid, and depression symptoms than placebo. No significant difference in bereavement intensity or adverse safety impact were observed. Source: https://www.sciencedirect.com/
A Spanish secondary prevention study suggested that Mediterranean diet might reduce neutrophil levels and slow…
Top 10 key takeaway points of the report of the American College of Cardiology Solution…
A UK device-based prospective study suggested that irregular sleep was associated with higher risk of…
A Chinese parallel design, randomized clinical trial showed that the incidence of major cardiovascular events…
A study comparing UK adults conceived just before or after sugar rationing ended found that…
A Chinese nationwide case-crossover study revealed that lower temperatures were associated with higher risks of…
This website uses cookies.